Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Therapeutic vaccine improves response rate and extends progression-free survival in patients with metastatic melanoma

2009 ASCO Annual Meeting

29 May - 2 Jun 2009

Published: 3 Jul 2009

Views: 14762

Rating:

Save

Dr Patrick Hwu - M.D. Anderson Cancer Center, US

Patrick Hwu, MD, Chair of the Department of Melanoma Medical Oncology M. D. Anderson Cancer Center: Therapeutic Vaccine Improves Response Rate and Extends Progression-Free Survival in Patients with Metastatic Melanoma: Preliminary findings from a phase III, multicenter trial show that adding a novel cancer vaccine – called gp100:209-217(210M) peptide – to standard therapy doubles response rates and extends progression-free survival in patients with metastatic melanoma, without causing significant side effects.

Related Videos

IO102-IO103 cancer vaccine plus pembrolizumab demonstrates PFS benefit in advanced melanoma

Dr Inge Marie Svane - Copenhagen University Hospital, Copenhagen Denmark

IO102-IO103 cancer vaccine plus pembrolizumab demonstrates PFS benefit in advanced melanoma ( Dr Inge Marie Svane - Copenhagen University Hospital, Copenhagen Denmark )

The case for global gender-neutral HPV vaccination

Peter Baker, Global Action on Men's Health (United Kingdom)

The case for global gender-neutral HPV vaccination ( Peter Baker, Global Action on Men's Health (United Kingdom) )

Boosting HPV vaccination in India: A call to action

Ms Sutapa Biswas - Cancer Foundation of India, Kolkata, India

Boosting HPV vaccination in India: A call to action ( Ms Sutapa Biswas - Cancer Foundation of India, Kolkata, India )

Assessment of suicide risk in cancer patients

Prof Sujit Sarkhel - SSKM Hospital, Kolkata, India

Assessment of suicide risk in cancer patients ( Prof Sujit Sarkhel - SSKM Hospital, Kolkata, India )

Cancer journeys: Research from India

Ms. Soumita Ghose - Tata Medical Center, Kolkata

Cancer journeys: Research from India ( Ms. Soumita Ghose - Tata Medical Center, Kolkata )

Depression in cancer

Ms. Bidisha Samanta - Rocket Health, Kolkata, India

Depression in cancer ( Ms. Bidisha Samanta - Rocket Health, Kolkata, India )

Managing 'fear of recurrence' of cancer patients

Ms Bincy Mathew - Manipal Hospitals, Bangalore, India

Managing 'fear of recurrence' of cancer patients ( Ms Bincy Mathew - Manipal Hospitals, Bangalore, India )

Psychological issues in familial cancer

Dr Arnab Mukherjee - Tata Medical Center, Kolkata, India

Psychological issues in familial cancer ( Dr Arnab Mukherjee - Tata Medical Center, Kolkata, India )

3 year follow-up shows durable long-term RFS and DMFS benefit with mRNA-4157 plus pembrolizumab in resected melanoma

Dr Meredith McKean - Sarah Cannon Research Institute, Nashville, USA

3 year follow-up shows durable long-term RFS and DMFS benefit with mRNA-4157 plus pembrolizumab in resected melanoma ( Dr Meredith McKean - Sarah Cannon Research Institute, Nashville, USA )

More from ecancer